|
SMG5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.392000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.730370E-01 |
| Normal-vs-Stage2 |
2.054200E-01 |
| Normal-vs-Stage3 |
4.064600E-03 |
| Normal-vs-Stage4 |
2.870400E-01 |
| Stage1-vs-Stage2 |
6.269000E-01 |
| Stage1-vs-Stage3 |
4.785900E-02 |
| Stage1-vs-Stage4 |
9.196200E-01 |
| Stage2-vs-Stage3 |
3.851400E-01 |
| Stage2-vs-Stage4 |
7.508200E-01 |
| Stage3-vs-Stage4 |
1.664760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.200080E-02 |
| Normal-vs-AfricanAmerican |
6.985800E-01 |
| Normal-vs-Asian |
7.262600E-01 |
| Caucasian-vs-AfricanAmerican |
3.896100E-02 |
| Caucasian-vs-Asian |
2.850400E-01 |
| AfricanAmerican-vs-Asian |
7.779200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.442750E-03 |
| Normal-vs-Female |
8.882600E-01 |
| Male-vs-Female |
2.640600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.856770E-03 |
| Normal-vs-Age(41-60Yrs) |
7.937600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.877900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.127200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.491500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.055640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.242000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.416800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.701400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.539000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.018040E-01 |
| Normal-vs-Grade 2 |
7.352500E-02 |
| Normal-vs-Grade 3 |
3.340300E-02 |
| Normal-vs-Grade 4 |
8.398100E-02 |
| Grade 1-vs-Grade 2 |
1.194090E-02 |
| Grade 1-vs-Grade 3 |
1.487620E-02 |
| Grade 1-vs-Grade 4 |
8.742400E-03 |
| Grade 2-vs-Grade 3 |
6.043200E-01 |
| Grade 2-vs-Grade 4 |
7.312800E-01 |
| Grade 3-vs-Grade 4 |
9.572200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.799000E-01 |
| Normal-vs-ccB subtype |
4.165500E-04 |
| ccA subtype-vs-ccB subtype |
1.136970E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.856420E-02 |
| Normal-vs-N1 |
3.033400E-01 |
| N0-vs-N1 |
8.000500E-02 |
|
|
